MedAvante: WCG's MedAvante-ProPhase expands executives

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, announced that industry experts Steven Herne and Michael Cioffi have joined the leadership of MedAvante–ProPhase, the Group’s electronic clinical outcomes assessment (eCOA) arm. Herne and Cioffi are tasked with expanding MedAvante-ProPhase’s already formidable portfolio of services and technologies, which improve the quality of clinical trial data collection and analysis in the fields of CNS and mental health.